Ayurvedic perspective and management of COVID- 19 : A Critical Review

Dr. Sisir Kumar Mandal; Dr. Meenakshi Sharma; Dr. Sisir Kumar Mandal

doi:10.21760/jaims.v5i05.1084

Dr. Sisir Kumar Mandal Associate Professor, Dept. of Rog Nidan evum Vikriti Vigyan, All India Institute of Ayurveda, Delhi, INDIA.
Dr. Meenakshi Sharma Associate Professor, Dept. of Rog Nidan evum Vikriti Vigyan, All India Institute of Ayurveda, Delhi, INDIA.
Dr. Sisir Kumar Mandal Associate Professor, Dept. of Rog Nidan evum Vikriti Vigyan, All India Institute of Ayurveda, Delhi, INDIA.

DOI: https://doi.org/10.21760/jaims.v5i05.1084

Keywords: Chaturthaka Jvara, COVID-19, Coronavirus, Janapadoddhvansa, Rasayana

Abstract

Recently, there is an emergence and outbreak of a new viral disease i.e. COVID-19 which is spreading faster than ever in many different regions of the world. COVID-19 is an infectious disease caused by a newly discovered coronavirus which spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. It is a respiratory disease and most infected people will develop mild to moderate symptoms but according to WHO data, maximum number of patients related to Covid-19 are associated with common symptoms including fever, dry cough, shortness of breath, tiredness and sore throat. This new virus seems to be very contagious and has quickly spread globally. At present there are no specific vaccine or treatment for Covid-19 in contemporary science, however it is known that Ayurveda provides a potential holistic approach from many centuries and proven to be the most efficient tool in health management system. Therefore, an effort has been made to find possible Ayurvedic comparison to the current most prevalent COVID-19 disease based on particular signs and symptoms and to explain its management.

Downloads

Download data is not yet available.

References

https://www.ncbi.nlm.nih.gov/pubmed/32150360 Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). 2020 Mar 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 32150360

https://www.who.int/news-room/q-a-detail/q-acoronaviruses. Last accessed on 22/04/20

Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009 Jun;7(6):439-50.

https://en.wikipedia.org/wiki/2019– 20_coronavirus_pandemic#cite_note-fn1-1.Last accessed on 23/04/20.

Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, Yuen KY. Genomic characterization of the 2019 novel humanpathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221-236

https://www.emro.who.int/health-topics/coronavirus/questions-and-answers.html.Last accessed on 24/04/20.

https://www.who.int/dg/speeches/detail/whodirector-general-s-opening-remarks-at-the-mediabriefing-on-covid-19---11-march-2020. Last accessed on 24/04/20.

Melina Hosseiny, Soheil Kooraki, Ali Gholamrezanezhad, Sravanthi Reddy, Lee Myers,:Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute
Respiratory Syndrome and Middle East Respiratory Syndrome. American Journal of Roentgenology:2020;1DOI:10.2214/AJR.20.22969

https://www.ajronline.org/doi/abs/10.2214/AJR.20.22 969

Acharya JT, editor. Charaka Samhita of Charaka, Vimana Sthana;Janapadoddavansniya Adhyaya: Chapter 3, Verse 2. Varanasi: Chaukhambha Orientalia; 2014.p.240.reprint2011.